Related Experiment Video

Updated: Aug 19, 2026

Electrophysiological Measurements and Analysis of Nociception in Human Infants
09:18

Electrophysiological Measurements and Analysis of Nociception in Human Infants

Published on: December 20, 2011

The pharmacological treatment of neonatal pain

D Tibboel1, K J S Anand, J N van den Anker

  • 1Sophia Foundation Professor of Experimental Pediatric Surgery, Head Pediatric Surgical Intensive Care Unit, Erasmus MC-Sophia, Department of Pediatric Surgery, Dr. Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands. d.tibboel@erasmusmc.nl

Seminars in Fetal & Neonatal Medicine
|February 11, 2005
PubMed

Insights

Providing optimal pain relief for critically ill newborns is challenging. Opioid use in extremely premature infants requires careful consideration due to unique metabolic and clearance differences, with long-term effects needing more study.

Area of Science:

  • Neonatalogy
  • Pharmacology
  • Pain Management

Background:

  • Optimal analgesia in critically ill newborns is a significant clinical challenge.
  • Infants with extreme very low birth weight exhibit unique drug metabolism and renal clearance.
  • This necessitates tailored approaches for opioid analgesia, differing from older infants.

Purpose of the Study:

  • To highlight the challenges in providing optimal analgesia for critically ill newborns.
  • To discuss the pharmacokinetic differences in opioid use (morphine, fentanyl) in extremely low birth weight infants.
  • To emphasize the need for further research on long-term effects of opioids in this vulnerable population.

Main Methods:

  • Review of current literature on pain management in critically ill neonates.
  • Analysis of pharmacokinetic changes related to liver enzyme maturation and renal clearance.
  • Examination of existing randomized controlled trials and guidelines for acute/procedural pain.

Main Results:

  • Opioid analgesia, including morphine and fentanyl, presents unique considerations in extremely low birth weight infants.
  • Established guidelines exist for acute and procedural pain management.
  • Long-term outcomes of opioid administration in this specific cohort remain largely unevaluated.

Conclusions:

  • Managing pain effectively in critically ill newborns is complex.
  • Pharmacokinetic variations in extremely low birth weight infants impact opioid therapy.
  • Further investigation into the long-term consequences of opioid exposure is crucial for this vulnerable group.

More Related Videos

A Preterm Rat Model for Pain Studies01:37

A Preterm Rat Model for Pain Studies

Published on: February 9, 2024

Electrophysiological Measurement of Noxious-evoked Brain Activity in Neonates Using a Flat-tip Probe Coupled to Electroencephalography06:29

Electrophysiological Measurement of Noxious-evoked Brain Activity in Neonates Using a Flat-tip Probe Coupled to Electroencephalography

Published on: November 29, 2017

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...